AXID ORAL SOLUTION Rx
Generic Name and Formulations:
Nizatidine 15mg/mL; bubble gum flavor.
Braintree Laboratories, Inc.
Indications for AXID ORAL SOLUTION:
Active duodenal ulcer. Maintenance of healed duodenal ulcer. Benign gastric ulcer. Gastroesophageal reflux disease (GERD): including heartburn and erosive and ulcerative esophagitis.
Active duodenal or benign gastric ulcer: 300mg daily at bedtime or 150mg twice daily, both for up to 8 weeks. Maintenance: 150mg daily at bedtime. GERD: 150mg twice daily for up to 12 weeks. Renal impairment: see literature.
Rule out malignant gastric ulceration. Renal insufficiency, reduce dose (see literature). Elderly. Pregnancy (Cat.B). Nursing mothers: not recommended.
May elevate serum salicylate levels in high-dose aspirin patients.
Headache, anemia, diarrhea, dizziness, sweating, rhinitis, urticaria.
Caps—contact supplier; Soln—480mL
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Attention-Deficit/Hyperactivity Disorder Increasing Among US Children and Adolescents
- Suicide Attempt Risk Among LGB Populations Higher Than Previously Estimated
- Residents Should Take Advantage of Paid Time Off
- Outpatient Engagement May Lower Suicide Attempts in Patients With Fibromyalgia
- Prevalence of Alzheimer Disease, Related Dementia Set to Double
- Forms of Childhood Adversity Related to First-Episode Psychosis Outcomes